gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Kahler Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anglade, MC; Dao, TH; Divine, M; Golli, M; Jazaerli, N; Mathieu, D; Rahmouni, A; Reyes, F; Vasile, N | 1 |
| Anglade, MC; Dao, T; Divine, M; Golli, M; Haioun, C; Mathieu, D; Rahmouni, A; Reyes, F; Vasile, N | 1 |
2 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Kahler Disease
| Article | Year |
|---|---|
Detection of multiple myeloma involving the spine: efficacy of fat-suppression and contrast-enhanced MR imaging.
Topics: Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Organometallic Compounds; Prospective Studies; Spinal Neoplasms; Spine | 1993 |
MR appearance of multiple myeloma of the spine before and after treatment.
Topics: Combined Modality Therapy; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Organometallic Compounds; Prospective Studies; Spinal Neoplasms; Spine | 1993 |